$PBP - Probiotec Limited starting a new run?Great steady growth throughout the year with a bit of a hiccup during the October volatility. Looks like it might be coming out of it after a retest of the lows.
Has better financials than most of the speculative stocks in the sector.
Probiotec Limited is engaged in the development, manufacture
0.11AUD
11.02 MAUD
214.03 MAUD
45.04 M
About PROBIOTEC LIMITED
Sector
CEO
Wesley Stringer
Headquarters
Melbourne
Website
Founded
1997
ISIN
AU000000PBP7
FIGI
BBG000Q5HQV9
Probiotec Ltd. engages in manufacture, market and distribution of over-the-counter pharmaceuticals, complementary medicines and specialty ingredients. It operates through the following segments: Branded Pharmaceuticals, Contract Manufacturing, Obesity and Weight Management, Europe, and Specialty Products. The Branded Pharmaceuticals segment involves the sale of branded pharmaceutical products. The Contract Manufacturing segment involves the contract manufacturing of pharmaceutical, food and animal nutrition products on behalf of domestic and international pharmaceutical and food companies. The Obesity and Weight Management segment is involved in the manufacture and sale of a range of products across a number of channels including FMCG, pharmacy, health food stores and online. The Europe segment is involved in the manufacture and sale of products within Europe. The Specialty Products segment involves in the sale of human and animal nutrition products, incorporating the sale of ingredients and additives for use in the pharmaceutical and food industries. The company was founded in 1997 and is headquartered in Melbourne, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PBP is 2.85 AUD — it has decreased by 0.35% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PROBIOTEC LIMITED stocks are traded under the ticker PBP.
PROBIOTEC LIMITED is going to release the next earnings report on Aug 21, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for PROBIOTEC LIMITED has a max estimate of 3.00 AUD and a min estimate of 3.00 AUD.
PBP earnings for the last quarter are 0.08 AUD whereas the estimation was 0.09 AUD which accounts for −5.68% surprise. Estimated earnings for the next quarter are 0.07 AUD. See more details about PROBIOTEC LIMITED earnings.
PROBIOTEC LIMITED revenue for the last quarter amounts to 107.30 M AUD despite the estimated figure of 111.70 M AUD. In the next quarter revenue is expected to reach 113.96 M AUD.
Yes, you can track PROBIOTEC LIMITED financials in yearly and quarterly reports right on TradingView.
Like other stocks, PBP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROBIOTEC LIMITED stock right from TradingView charts — choose your broker and connect to your account.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. PROBIOTEC LIMITED EBITDA is 34.61 M AUD, and current EBITDA margin is 16.25%. See more stats in PROBIOTEC LIMITED financial statements.